13075_2017_1466_MOESM1_ESM.pdf (528.6 kB)
Additional file 1: of Use of a baseline risk score to identify the risk of serious infectious events in patients with rheumatoid arthritis during certolizumab pegol treatment
journal contribution
posted on 2017-12-15, 05:00 authored by Jeffrey Curtis, Kevin Winthrop, Cathy OâBrien, Matladi Ndlovu, Marc de Longueville, Boulos HaraouiMethods: testing of RABBIT Risk Score in the All CZP group. Table S1. Observed number of SIEs in patients categorized by AACI. Figure S1. Predicted and observed SIE rates in All CZP patients according to the RABBIT Risk Score. (PDF 178 kb)